Kailera Therapeutics, Inc. (KLRA)

NASDAQ: KLRA · Real-Time Price · USD

19.90

+0.77 (4.03%)

At close: Jun 18, 2026, 4:00 PM EDT

19.51

-0.39 (-1.96%)

After-hours: Jun 18, 2026, 7:12 PM EDT

Kailera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.02	0.02	-
Net Debt / Equity Ratio	1.18	1.50	-
Net Debt / EBITDA Ratio	-	3.39	-
Net Debt / FCF Ratio	-	4.38	-
Quick Ratio	9.47	11.77	-
Current Ratio	9.67	12.01	-
Return on Equity (ROE)	-	-46.85%	-
Return on Assets (ROA)	-	-45.74%	-
Return on Invested Capital (ROIC)	-	-233.20%	-
Return on Capital Employed (ROCE)	-	-49.03%	-
Buyback Yield / Dilution	-	-15600.00%	-
Total Shareholder Return	-	-15600.00%	-

SEC Filings: 10-K · 10-Q